FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:2035-2036 May 7, 2009 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: In 1984, the Journal was one of the first medical journals to establish a policy requiring disclosure of financial interests for all authors of research articles. During the past 25 years, all medical specialties have been grappling with how best to manage conflicts of interest. Today, the field of psychiatry is perceived to have suffered a unique "crisis of credibility" with respect to the growing influence of pharmaceutical companies on organized psychiatry.¹

The reaction of the organization that is increasingly in question, the American Psychiatric Association (APA), has ranged from calling for greater transparency — mandating that . . . [Full Text of this Article]

This article has been cited by other articles:

• Oguntoye, A., Bursztajn, H. J. (2009). Commentary: Inadequacy of the Categorical Approach of the DSM for Diagnosing Female Inmates With Borderline Personality Disorder and/or PTSD. J Am Acad Psychiatry Law 37: 306-309 [Abstract] [Full Text]